1.0 2016-05-19 02:30:57 UTC 2026-05-14 16:24:12 UTC XANTHOPHYLL SmallMolecule XANTHOPHYLL (C40H56O2) belongs to the tetraterpenoids, a subclass of prenol lipids within the organic compounds. With an average molecular weight of 568.89 g/mol, XANTHOPHYLL is a heavy molecule. Industrially, it is used as a softener and conditioner, while biologically it functions as an antioxidant (PMC12157995). This compound is found in 21 recorded sources, including food, food processing and cookware—specifically the preparation of malt, vinegar, wort, wine or sparkling wine, and molasses and the treatment of molasses—as well as household cleaning and consumer products such as tobacco pipes, tobacco product cases, pipe accessories, other smoking requisites, and non electric simulated smoking devices. It is also released from electrical and electronic equipment, including communication cables or conductors, line transmission systems, antennas, amplifiers, and colour television systems. XANTHOPHYLL is used as a treatment for diabetic retinopathy and glaucoma (PMC10992905). It has a therapeutic effect on diabetic retinopathy (PMC5793074) and atherosclerosis (PMC10992905). The compound is associated with a decrease in obesity (PMC12732708), atherosclerosis (PMC4626686), and various forms of cancer, including lung cancer (PMC5000748), prostate cancer (PMC3823537), and skin cancer (PMC8776015). It is further linked to an inverse relationship with breast cancer (PMC10220911, PMC11303474) and a general decrease in cancer (PMC3257702). Additionally, blood levels of XANTHOPHYLL are decreased in cases of diabetes mellitus (PMC5793074). Lutein C40H56O2 568.886 568.428031043 (1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1R)-4-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol (1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1R)-4-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol 127-40-2 C\C(\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C InChI=1S/C40H56O2/c1-29(17-13-19-31(3)21-23-37-33(5)25-35(41)27-39(37,7)8)15-11-12-16-30(2)18-14-20-32(4)22-24-38-34(6)26-36(42)28-40(38,9)10/h11-25,35-37,41-42H,26-28H2,1-10H3/b12-11+,17-13+,18-14+,23-21+,24-22+,29-15+,30-16+,31-19+,32-20+/t35-,36+,37-/m0/s1 KBPHJBAIARWVSC-RGZFRNHPSA-N Organic compounds Lipids and lipid-like molecules Prenol lipids Tetraterpenoids Xanthophylls Hydrocarbon derivatives Secondary alcohols Alcohol Aliphatic homomonocyclic compound Hydrocarbon derivative Organic oxygen compound Organooxygen compound Secondary alcohol Xanthophyll Aliphatic homomonocyclic compounds Detected and Not Quantified Lutein Drug Metabolism Action Pathway SMP0142611 logp 8.55 logp 8.29 ALOGPS logs -5.89 ALOGPS solubility 7.32e-04 g/l ALOGPS logp 8.55 ChemAxon pka_strongest_acidic 18.22 ChemAxon pka_strongest_basic -0.91 ChemAxon iupac (1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(1R)-4-hydroxy-2,6,6-trimethylcyclohex-2-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-3,5,5-trimethylcyclohex-3-en-1-ol ChemAxon average_mass 568.886 ChemAxon mono_mass 568.428031043 ChemAxon smiles C\C(\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C ChemAxon formula C40H56O2 ChemAxon inchi InChI=1S/C40H56O2/c1-29(17-13-19-31(3)21-23-37-33(5)25-35(41)27-39(37,7)8)15-11-12-16-30(2)18-14-20-32(4)22-24-38-34(6)26-36(42)28-40(38,9)10/h11-25,35-37,41-42H,26-28H2,1-10H3/b12-11+,17-13+,18-14+,23-21+,24-22+,29-15+,30-16+,31-19+,32-20+/t35-,36+,37-/m0/s1 ChemAxon inchikey KBPHJBAIARWVSC-RGZFRNHPSA-N ChemAxon polar_surface_area 40.46 ChemAxon refractivity 195.06 ChemAxon polarizability 73.38 ChemAxon rotatable_bond_count 10 ChemAxon acceptor_count 2 ChemAxon donor_count 2 ChemAxon physiological_charge 0 ChemAxon formal_charge 0 ChemAxon #<HealthEffect::ActiveRecord_Associations_CollectionProxy:0x00007f3baf76ddf0> DB00137 5281243 4444655